| Literature DB >> 35910649 |
Wenjia Hou1, Guorui Shi1, Songze Wu2, Jiayi Mo1, Lan Shen1, Xiuqiang Zhang3, Yabin Zhu1.
Abstract
Antimicrobial photodynamic inactivation (aPDI) is a newly emerged treatment approach that can effectively address the issue of multidrug resistance resulting from the overuse of antibiotics. Fullerenes can be used as promising photosensitizers (PSs) for aPDI due to the advantages of high triplet state yields, good photostability, wide antibacterial spectrum, and permissibility of versatile functionalization. This review introduces the photodynamic activities of fullerenes and the up-to-date understanding of the antibacterial mechanisms of fullerene-based aPDI. The most recent works on the functionalization of fullerenes and the application of fullerene derivatives as PSs for aPDI are also summarized. Finally, certain remaining challenges are emphasized to provide guidance on future research directions for achieving clinical application of fullerene-based aPDI.Entities:
Keywords: antibacterial; antimicrobial photodynamic inactivation; fullerene derivatives; functionalization; multidrug resistance; photosensitizers
Year: 2022 PMID: 35910649 PMCID: PMC9329950 DOI: 10.3389/fmicb.2022.957698
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Advantages and disadvantages of commonly used PSs.
| Class | PS | Advantages | Disadvantages | References |
| Photofrin and its derivatives | Hematoporphyrin and its derivatives (HpD) | First-generation PS | Slow metabolization; strong histotoxicity; low active constituent content; short adsorption wavelength; cause skin allergies |
|
| Verteporfin; 5-aminolevulinic acid (5-ALA); hematoporphyrin monomethyl ether (HMME); Temoporfin (m-THPC) | High 1O2 yields; high phototoxicity | Slow metabolization; low immune clearance rate; poor photostability; poor water solubility | ||
| Phthalocyanine-based PS | Silicon(IV) phthalocyanine Pc4; Zinc(II) phthalocyanines | Physicochemical stability; long adsorption wavelengths (660–720 nm, with a 50-time higher adsorption at 680 nm); high immune clearance rate; low toxicity in dark | Poor water solubility; prone to agglomerate; low 1O2 yields in oxygen deprivation |
|
| Polycyclic quinone PS | Riboflavin; curcumin; hypericin; hypocrellin | Easy purification; high quantum yields; high phototoxicity; low toxicity in dark; good biocompatibility | Short adsorption wavelengths (400–500 nm); poor water solubility; prone to agglomerate | |
| Xanthene dyes | Rhodamine; fluorescein | Good water solubility; high fluorescence quantum yields; high molar extinction coefficient; good biocompatibility; low cytotoxicity | Poor chemical stability; poor photostability; short adsorption wavelengths (∼500 nm) |
|
| 4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) | Easy modification; good photophysical and photochemical stability; high fluorescence quantum yields; absorption and emission in the visible region with high molar absorption coefficients | Poor water solubility; low triplet state yield; low 1O2 yield | ||
| Transition metal complexes | Ruthenium (II); rhodium; iridium; platinum (II); gold (III) | High ROS yields; high immune clearance rate | Short excitation wavelengths; low penetration depths; poor biocompatibility | |
| Fullerene derivatives | High triplet state yields (∼100%); high ROS yields; good photostability; able to generate highly toxic hydroxyl radicals | Short adsorption wavelengths (400∼ 500 nm); low penetration depths; poor water solubility |
FIGURE 1Schematic representation of the photodynamic activities of fullerenes (Heredia et al., 2022). A: Photoexcitation of fullerenes to the singlet state; B: Transition from the singlet state to the triplet state by ISC; C: Charge transfer to surrounding biomolecules to form ROS (Type-I mechanism); D: Fullerenes can further transfer an electron to O2 to form O2⋅–; and E: Energy transfer from the excited triplet state to O2 to form 1O2 (Type-II mechanism).
FIGURE 2Schematic representation of the photodynamic antibacterial mechanisms of fullerenes.
FIGURE 3Molecular structures of the fullerene-pyrrolidine derivatives. (A) DTC602+. (B) DAC60+ (Spesia et al., 2008). (C) Mono-N-methylpyrrolidinium fullerene iodide (Grinholc et al., 2015). (D) MPC60 and DPC602+ (Agazzi et al., 2015). (E) DMC603+ (Agazzi et al., 2021).
FIGURE 4Molecular structures of the fullerene-cyclopropane derivatives, LC14–LC20 (Sperandio et al., 2013; Yin et al., 2015).
FIGURE 5Molecular structures of the fullerene derivatives with a light-harvesting antenna. (A) BDP-C60, aBDP, and MC60 (Agazzi et al., 2019b). (B) BP-C60 (Lopez et al., 2021). (C) Distryl-BODIPY-cyclotriphosphazene-fullerene triad (Sarikaya et al., 2019). (D) Schematic diagram of LMIcatC60–light-harvesting antenna molecules (Kawasaki et al., 2020). (E) GO-C60 (Li et al., 2017).
FIGURE 6(A) The molecular structure of C60-functionalized amino acid with N-Fmoc-L-glutamic acidr-tert-butyl ester (Pellarini et al., 2001). (B) The molecular structure of Fgu (Pantarotto et al., 2002). (C) Schematic diagram of Fmoc-FF/C60-PTC hydrogel (Zhang et al., 2018).
FIGURE 7(A) Schematic diagram of the fabrication of PC71BM/g-C3N4 photocatalysts. (B) SEM images of E. coli and S. aureus before and after irradiation for 135 min with PC71BM/g-C3N4 (Liu et al., 2022).